Compliance
More than 80% of the expected drug intake at week 16 was defined as good compliance with the medication. The compliance was good in both groups among participants who completed the 16-week trial, as 100% in the ALN-EFF group and 96.3% in the ALN group were compliant, respectively. One participant in the ALN group had a compliance of 75%.